Rouan Sarah Kathryn 4/A
4/A · Viking Therapeutics, Inc. · Filed Apr 8, 2025
Insider Transaction Report
Form 4/AAmended
Rouan Sarah Kathryn
Director
Transactions
- Purchase
Common Stock, par value $0.00001 per share
2025-03-31$24.15/sh+1,240$29,943→ 1,240 total
Footnotes (1)
- [F1]The Reporting Person's purchase of shares of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 1,240 shares, with the Reporting Person's sale of shares of the Issuer's common stock at a price of $80.89 per share on October 25, 2024. The Reporting Person has, on a voluntary basis, made arrangements with the Issuer to pay $70,316.25 to the Issuer, representing the full amount of the profit realized in connection with the short-swing transaction, less transactions costs.